Is Selling Advanced Oncotherapy PLC Here a Winning Strategy?

 Is Selling Advanced Oncotherapy PLC Here a Winning Strategy?

The stock of Advanced Oncotherapy PLC (LON:AVO) is a huge mover today! The stock decreased 2.27% or GBX 2 on November 23, hitting GBX 86. About 36,774 shares traded hands. Advanced Oncotherapy PLC (LON:AVO) has declined 48.80% since April 25, 2016 and is downtrending. It has underperformed by 54.13% the S&P500.
The move comes after 9 months negative chart setup for the GBX 62.24 million company. It was reported on Nov, 23 by Barchart.com. We have GBX 79.98 PT which if reached, will make LON:AVO worth GBX 4.36 million less.

Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The company has a market cap of 62.24 million GBP. The Firm is engaged in development and then building of the Linac Image Guided Hadron Technology proton beam cancer therapy device and management of healthcare related property. It currently has negative earnings. The Company’s divisions include Development of Proton Therapy-UK; Development of Proton Therapy-Switzerland; Development of Proton Therapy-USA, and Healthcare-related properties-UK.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment